Related Experiment Video
Updated: Jul 7, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Decoding Thrombocytopenia in Dengue: Platelet Indices Define Mechanistic Phenotypes and Predict Bleeding Risk
1Department of Hematology, Port Sudan Ahlia University, Port Sudan, SDN.
Dengue infection causes thrombocytopenia with diverse underlying mechanisms. While platelet indices offer insights, severe dengue disease remains the primary predictor of bleeding risk, not the specific thrombocytopenia phenotype.
Area of Science:
- Hematology
- Infectious Diseases
- Clinical Medicine
Background:
- Thrombocytopenia is a common clinical feature of dengue infection.
- The mechanisms driving thrombocytopenia in dengue are not fully understood.
- Platelet indices offer a potential avenue for mechanistic classification and risk assessment.
Purpose of the Study:
- To categorize dengue-associated thrombocytopenia phenotypes using platelet indices.
- To assess the association between these phenotypes and bleeding risk.
- To evaluate the diagnostic performance of platelet indices for predicting bleeding and develop a Dengue Bleeding Risk Score (DBRS).
Main Methods:
- A case-control study involving 334 dengue patients and 101 controls.
- Analysis of various platelet indices (PLT, PCT, IPF, MPC, MPV, PDW, PLCR, PLCC) and coagulation parameters.
- Classification of thrombocytopenia into four phenotypes (hyperdestructive, inadequate response, hypoproductive, lazy-suppressed) based on PLT and IPF; logistic regression and ROC analyses for bleeding risk.
Main Results:
- Thrombocytopenia observed in 82.9% of dengue cases, with 'inadequate response' being most frequent (55.7%).
- A shift towards the 'hyperdestructive' phenotype correlated with increased disease severity (p < 0.001).
- Severe dengue was the strongest predictor of bleeding (adjusted OR 41.83), while IPF and MPC showed moderate bleeding prediction (AUC ~0.72).
Conclusions:
- Dengue thrombocytopenia presents heterogeneous, mechanism-based phenotypes.
- Bleeding risk is predominantly driven by overall disease severity, not solely by the thrombocytopenia phenotype.
- Integrating platelet indices into models like the DBRS may enhance risk stratification beyond platelet count alone, requiring further validation.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

